Skip to main content
Alison (Hall) Skalet, MD, Ophthalmology, Portland, OR

AlisonHall(Hall)SkaletMD

Ophthalmology Portland, OR

Retinal Disease, Ocular Oncology

Associate Professor, Ophthalmology, Oregon Health and Science University School of Medicine

Dr. Skalet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Skalet's full profile

Already have an account?

  • Office

    3375 SW Terwilliger Blvd
    Portland, OR 97239
    Phone+1 503-494-7881
    Fax+1 503-494-3339

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityFellowship, Ocular Oncology/Ophthalmic Pathology, 2011 - 2012
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Ophthalmology, 2008 - 2011
  • Childrens Hospital of Philadelphia
    Childrens Hospital of PhiladelphiaInternship, Transitional Year, 2006 - 2007
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2025
  • OR State Medical License
    OR State Medical License 2011 - 2025
  • PA State Medical License
    PA State Medical License 2006 - 2007
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Risk Factors and Disease Course for Blood-Brain Barrier Disruption–Associated Maculopathy  
    Joseph M Simonett, Alison H Skalet, Brandon J Lujan, JAMA Ophthalmology

Press Mentions

  • Genetic Testing Recommended for Children Considered at Risk for Most Common Eye Cancer
    Genetic Testing Recommended for Children Considered at Risk for Most Common Eye CancerOctober 18th, 2017

Professional Memberships

  • International Society of Ocular Oncology
    Member
  • American Association of Ophthalmic Oncologists and Pathologists
    Member